SCD and hepatocellular carcinoma: Notable, the intestinal ablation of Scd1 increases steatohepatitis and HCC in a murine model, blunting the LXRs’ activity and decreasing the hepatic monounsaturated fatty acids level with an increase of cholesterol accumulation in the liver [25].